Merck (MRK) EPS (Basic) (2009 - 2026)
Merck (MRK) posted quarterly EPS (Basic) of -$1.7 for Q1 2026, down 184.48% year-over-year from $2.02 in Q1 2025, and down 243.82% quarter-over-quarter from $1.18 in Q4 2025.
Merck (MRK) EPS (Basic) (2009 - 2026) Analysis & Trends
Merck (MRK) has reported EPS (Basic) for 17 consecutive years, with -$1.7 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 184.48% year-over-year to -$1.7; the TTM figure through Mar 2026 stood at $3.63 (down 47.55% YoY), while the FY2025 annual figure was $7.3, up 7.87% from the prior year.
- EPS (Basic) declined to -$1.7 in Q1 2026 per MRK's latest filing, from $1.18 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.32 in Q3 2025 and bottomed at -$2.35 in Q2 2023.
- Historically, EPS (Basic) has averaged $0.96 across 4 years, with a median of $1.48 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 405.99% — and 2026, when it plunged 184.48%.
- Merck's EPS (Basic) stood at -$0.48 in 2023, then jumped by 405.99% to $1.48 in 2024, then dropped by 19.94% to $1.18 in 2025, then plunged by 243.82% to -$1.7 in 2026.
- Business Quant data shows MRK's EPS (Basic) at -$1.7 in Q1 2026, $1.18 in Q4 2025, and $2.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.29 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.54 |
| Mar 31, 2026 | -1.70 |
| Dec 31, 2025 | 1.18 |
| Sep 30, 2025 | 2.32 |
| Jun 30, 2025 | 1.76 |
| Mar 31, 2025 | 2.02 |
| Dec 31, 2024 | 1.48 |
| Sep 30, 2024 | 1.25 |
| Jun 30, 2024 | 2.16 |
| Mar 31, 2024 | 1.88 |
| Dec 31, 2023 | -0.48 |
| Sep 30, 2023 | 1.87 |
| Jun 30, 2023 | -2.35 |
| Mar 31, 2023 | 1.11 |
| Dec 31, 2021 | -0.02 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | 0.17 |
| Dec 31, 2020 | 0.21 |
| Sep 30, 2020 | 0.24 |
| Jun 30, 2020 | 0.26 |